Baptist Hospital’s Miami Cancer Institute Awarded Cancer Research and Education Grant by IBA

Proton therapy
/
17.11.2017

 

Reston, VA - November 17, 2017 IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announced that the company will collaborate with Miami Cancer Institute at Baptist Hospital of Miami to develop a significant cancer research and education program. The grant is earmarked to further proton therapy research and education by helping pave the way for broader clinical indications of proton therapy. It will also promote physics, dosimetry, preclinical and clinical research approaches to enhance the effectiveness of this cancer treatment being offered for the very first time in South Florida.

Miami Cancer Institute is equipped with the most comprehensive suite of advanced radiotherapy equipment highlighted by the state-of-the-art IBA Proteus®PLUS solution equipped with a three-gantry, beam matched configuration using a dual-spot, robotic couch and pencil beam scanning delivery technique that is guided by surface and cone-beam CT imaging. The proton therapy center will be the first in South Florida with extensive reach to the Caribbean, Latin America and beyond. The $430 million Institute also provides a world-class array of advanced radiation therapy treatment options including Gamma Knife radiosurgery, CyberKnife stereotactic radiation therapy, tomotherapy and volumetric modulated arc therapy (VMAT), brachytherapy, MR guided linac-based radiation therapy, GRID therapy, and radioisotope therapy. Miami Cancer Institute is one of the only cancer centers in the world to offer all of the latest radiation therapy modalities under one roof. Additionally, Miami Cancer Institute clinical research trials and personalized genomic/molecular medicine are all delivered in a highly sophisticated, patient-friendly environment with the highest quality clinical standards as established with the Memorial Sloan Kettering Cancer Alliance.

“We are honored to partner with this esteemed cancer facility on furthering research focused on advancing proton therapy treatment for cancer patients.”shared Beth Klein, President IBA North America. “We support the vision and direction of Dr. Minesh Mehta, M.D., Deputy Director of the Miami Cancer Institute, Chief of Radiation Oncology for Baptist Health, and Professor and Chair of the Department of Radiation Oncology at Florida International University, to establish Miami Cancer Institute as a world class center for research and education in proton therapy with the goal to provide better outcomes for cancer patients. We look forward to the significant contributions Dr. Mehta and his team will make to proton therapy and patient treatments.”

Nicolas Bronchart, Executive Vice President of R&D, commented, ”Dr.Mehta has pulled together a world-class team of clinicians and medical physicists that will deliver his vision of establishing Miami Cancer Institute as a center for some of the most advanced cancer radiation therapy options. Our work together at Miami Cancer Institute will not only benefit the patients of South Florida but will potentially impact how cancer is treated throughout the world.”

Dr. Mehta stated: “Because Baptist Hospital and Miami Cancer Institute have committed major resources to the enhancement of comprehensive cancer care and research in the region, we have been very successful in attracting the best and most highly qualified individuals from around the world to participate in this exciting program which can be best characterized as having an optimal balance between the highest quality cancer care and cutting-edge research. This major research and educational grant further enhances this critical mission of ours.”

About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.

IBA is listed on the Pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at: www.iba-worldwide.com

About Miami Cancer Institute
Baptist Hospital’s Miami Cancer Institute is a major destination cancer center known for its leading clinical care, exceptional patient experience, advanced clinical research and state-of-the-art technology – including the first proton therapy center in South Florida with extensive reach to the Caribbean, Latin America and beyond. To accelerate its mission of hope, caring and innovation, Miami Cancer Institute has joined the Memorial Sloan Kettering Cancer Alliance, a dynamic partnership that will enable cancer patients to access potential breakthrough therapies in South Florida. For more information, visit MiamiCancerInstitute.com.

Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with ten hospitals (Baptist Hospital, Baptist Children’s Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital, West Kendall Baptist Hospital, Fishermen’s Community Hospital, Bethesda Hospital East and Bethesda Hospital West), nearly 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence. With this extensive network, Miami Cancer Institute and Baptist Hospital are uniquely positioned to serve a large portion of South Florida’s population with the most sophisticated cancer treatment options. The not-for-profit, faith-based Baptist Health has approximately 16,000 employees and 2,300 affiliated physicians. Baptist Health South Florida has been recognized as one of the 100 Best Companies to Work For in America and as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net and connect with us on Facebook at Facebook.com/baptistHealthSF and on Twitter and Instagram @BaptistHealthSF.

For further information, please contact:

IBA
Aymeric HARMANT
Global Marketing Director
+32 10 203 796
aymeric.harmant@iba-group.com

Share
Download